The new emerging generation of microsystems represents a major opportunity for a substantial EU economic growth, in an industry counting already more than 200.000 workers and a turnover in 2019 of €450 billion. The Mesomorph concept provides the means to overcome the following 4 main hurdles: 1. The intrinsic physic of microsystems doesn’t allow the simple downsizing of conventional technologies to industrialize micromanufacturing processes. Mesomorphallows to limit the number of micromanipulation tasks by integrating an all-in-onemachine featuring novel processes for the direct creation of functions (electronic, fluidic, optic) directly on a substrate, with a RESOLUTION down to 300nm, by combining multi-material addition (Two-Photon Polymerization, Atomic Layer 3D nano printing) and subtraction (Femtolaser micro-ablation) in a self-contained white room. 2. Because of the intrinsic slowness of physical processes at microscale, productivity cannot be achieved by sequencing multiple single steps. Mesomorph proposes a scaleup throughput by PARALLELIZATION and batch processing UP TO 50k PARTS/YEAR, leveraging a new multiple micronozzles system to extend the SADALP working area from 10x10mm up to 500x500mm, and concurrently leveraging on the beam splitting technique of a high-power fs laser for ablation. 3. Microsystems cannot be conceived with subcomponents. Mesomorph includes a specific Design-to-Lifevalue Platform to guide the development of new microsystems by fully exploiting the new processes. 4. Innovation cannot be limited by the financial risk associated with the necessary investments. Mesomorph implements a new “Manufacturing as a Service” business model in which all the value chain’s actors can benefit from a positive net cash flow since production's start, effectively removing entry barriers for innovators. Mesomorph consortium is composed of 13 partners from 5 different countries. Each partner represents excellence in its own field.

Borealis project presents an advanced concept of machine for powder deposition additive manufacturing and ablation processes that integrates 5 AM technologies in a unique solution. The machine is characterized by a redundant structures constituted by a large portal and a small PKM enabling the covering of a large range of working cube and a pattern of ejective nozzles and hybrid laser source targeting a deposition rate of 2000cm3/h with 30 sec set-up times. The machine is enriched with a software infrastructure which enable a persistent monitoring and in line adaptation of the process with zero scraps along with number of energy and resource efficiency optimization policies and harvesting systems which make the proposed solution the less environmental invasive in the current market. Borealis idea results from a consortium composed by the excellence of developers of worldwide recognized laser machines and advanced material processing together with the highly precision and flexible mechatronic designers. These two big clusters decided to join their expertise and focus on new manufacturing challenges coming from complex product machining in the field of aerospace, medtech and automotive represented by major partners in the market. Borealis project targets a TRL 6 and will provide as outcome of three years work two complete Borealis machine in two dimensions – a lab scale machine and a full size machine – which are foreseen to be translated into industrial solution by 2019.

WAVETAILOR focuses two industrial scenarios which are related to the complex multi-material component and assembly. The first one is Directed Energy Deposition of a multimaterial leading edge for a hypersonic hydrogen-driven airplane, while the second relates to the Powder Bed Fusion of complex multi-material assembly of a drone for urban delivery. The challenges in both cases are related with zero-defect manufacturing, sustainability and first-time-right manufacturing. WAVETAILOR aims to solve the high-precision in complex material structure manufacturing, the disassembly, reuse and recycling of components, while reducing the environmental footprint of both manufacturing process and the components itself. To achieve this, three main pillars are developed in the project: 1) flexible energy efficient photonic setup based on modular diode-based laser source and multi-wavelength optics; 2) full reconfigurability of this setup, to use minimal energy and material resources in manufacturing of two use cases and 3) ZDM and ZDW strategies at assembly level controlling the compliability of complex multimaterial products at machine level, shop floor level and delocalized manufacturing chain level. The latter pillar will be based on digital sibling (shop floor level) and twin (cloud level) for automatic assessment of component/assembly design for circularity; first-time right process planning using synthetic legacy data and ZDM/ZDW based on real time process and post-process monitoring. When the WAVETAILOR objectives are achieved, the manufacturing process of the two use cases will have spent 200MWh of energy less, 923kg of waste less, while the production costs are going to be 50-65% lower. In order to prove this a dedicated sustainability study is provided along the project.

Medtech products belongs to a huge expanding market, in which Europe hosts some of the biggest global player, accounting for 30% of the world market and for more than 575,000 people employed by nearly 25,000 medical technology companies – 95% of which are SMEs. Symbionica project focuses on the manufacturing of personalized bionics, smart endoprosthetics and exo-prosthetics that require geometric and functional customization. The Symbionica concept integrates an innovative machine performing deposition of advanced materials and subtractive processes along with a supply chain distributed co-engineering platform for advanced design and full personalization involving all relevant stakeholders, design and engineering of the products and through-life services. Symbionica manufacturing solution is conceived as a multi-material AM machine for material deposition and ablation, flexible and reconfigurable in the working cube, the material processing, the technology and the manufacturing strategy, with an advanced closed loop control methodology for product and process quality monitoring. This way Symbionica products are manufactured in one processing step, complex in shape, 3D structured and joint free. The Cooperative Design Platform will guarantee seamless data integration, reverse engineering from patient and parametric design to couple patient specific parts to standard ones. At the end, a Bionic Through-life Sensing System will support the patient to approach and gradually become comfortable with the prosthesis by assisting him with an exercise plan, a physiology monitoring platform and an on-line prosthesis data collection. The Symbionica consortium involves 3 LE, 6 SME and 2 RTD partners from 5 EU countries embracing the Medtech value chain from the patient and prosthetist to the technology providers of the mechatronics modules, IT solutions and control platforms.